ShinyBlackShoe (Calum Polwart)

@shinyblackshoe.bsky.social

🏴󠁧󠁢󠁳󠁣󠁴󠁿 consultant #oncology pharmacist working in 🏴󠁧󠁢󠁥󠁮󠁧󠁿 🇬🇧. #PharmSky #OncoSky Interested in #OncoPharm, Data science, #Rstats, Visualisation. ⛵🍝🥌🏞️📷🖥️ Self declared geek. Breast #bcsm, Prostate #pcsm, Lower GI #crcsm, Upper GI #esocsm & HPB #hpbcsm chemo.org.uk

Having a reflective evening as I mull over a conference abstract rejection. Did the abstract hit the wrong note? Did it not tell an interesting story? Did I somehow get the message wrong? Should I care? I've had plenty journal submissions desk rejected in minutes. Never a poster abstract...

journals.sagepub.com/doi/full/10.... Articles like this provide useful insight to the real world. I suspect the UK (sorry 🏴󠁧󠁢󠁥󠁮󠁧󠁿) has even more data on switching. We lack some outcome info. I bet clinicians wouldn't mind providing that if it was for use...

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

Anyone would think that dropping the FMD to claim a Brexit win had been a stupid idea. But you'd also think that if barcodes really made a difference to workflow, then market forces would push it to happen? Take a look at Aldi and Lidl packaging...

The Pharmaceutical Journal @pharmaj.bsky.social · 2w ago

The government is looking into which barcodes are required on medicines packaging, the Department of Health and Social Care has confirmed #ukpharmacy #druglabelling #communitypharmacy pharmaceutical-journal.com/article/news...

I've written to 'Thr Oncologist' because I think it's really important we try to keep the record clear - if there is an interaction with PPIs and palbociclib, the only evidence if for the old capsule formulation. doi.org/10.1093/onco... If we get generics and they are capsules that could matter.

Proton-Pump Inhibitor use in combination with a CDK4/6 inhibitor: Is formulation the issue?

Calum Polwart; Proton-Pump Inhibitor use in combination with a CDK4/6 inhibitor: Is formulation the issue?, The Oncologist, , oyag293, https://doi.org/10.1

doi.org

www.bbc.co.uk/news/article... My mind is blown. It feels like a sketch from Yes Minister! "Repay the generosity of the British people". You'd almost think that was the concept of taxation. That as those people earn they pay it forward? And as for this sentence 👇🏻

Refugees will be told to repay £10,000 under new asylum rules

Ministers will be given powers to recover costs from adults who have received asylum support under new laws.

bbc.co.uk

Mostly 📌 this here so I can read it in detail later. BUT my immediate thoughts are we usually struggle to agree what is 100% right when comparing human Vs human on MMM tasks. So human Vs LLM? If you get 80% correct, will that mean there is at least one error for every patient who has polypharmacy

medRxivpreprint@medrxivpreprint.bsky.social · 9mo ago

Rx-LLM: a benchmarking suite to evaluate safe LLM performance for medication-related tasks https://www.medrxiv.org/content/10.64898/2025.12.01.25341004v1

www.ft.com/content/5d6f... Wow. Rarely do I see a comments section so polarised. "Charitable" sponsorship offering "access" to key people is dodgy in my eyes. It's interesting sitting on the sidelines watching this stuff. Having previously been among it. You don't see conflict you are among

UK military top brass mix with defence executives at luxury Alpine event

Details of armed forces and industry attendees at Méribel competition raise concerns about conflicts of interest

ft.com